Skip to main content

Cholestasis and kidney dysfunction in liver transplant patients reduces cyclosporine metabolite excretion

  • Conference paper
Transplant International Official Journal of the European Society for Organ Transplantation
  • 15 Accesses

Abstract

Cyclosporin A (CsA) is metabolized principally by the hepatic cytochrome P 450-dependent microsomal enzyme system and eliminated virtually entirely as metabolites, mainly in the bile [1, 4, 6]. Only less than 1% of the oral dose is excreted unmetabolized in the urine or bile [5, 7]. Metabolites account for 50–70% of the total CsA in whole blood [3, 5, 8]. Some of the metabolites have been shown to possess an immunosuppressive and even toxic effect but the role of this effect remains uncertain [2, 9].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Berthallet-Peres P, Bonfils C, Fabre G, Just S, Cano J-P, Maurel P (1987) Metabolism of cyclosporin A. II. Implication of the mac-rolide antibiotic inductible cytochrome P 45 3c from rabbit liver microsomes. Drug Metab Dispos 15:391–398

    Google Scholar 

  2. Kahan BD (1989) Cyclosporine. N Engl J Med 321:1725–1738

    Article  PubMed  CAS  Google Scholar 

  3. Lensmeyer G, Wiebe D, Carlson I (1988) Deposition of nine metabolites of cyclosporin in human tissues, bile, urine and whole blood. Transplant Proc 20 [Suppl 2]: 614–622

    PubMed  CAS  Google Scholar 

  4. Mauer G (1985) Metabolism of cyclosporine. Transplant Proc 17 [Suppl 1]: 19–26

    Google Scholar 

  5. Mauer G, Lemaine M (1986) Biotransformation and distribution in blood of cyclosporine and its metabolites. Transplant Proc 18 [Suppl 5]: 25–34

    Google Scholar 

  6. Shaw LM (1989) Advances in cyclosporine pharmacology, measurement and therapeutic monitoring. CI Chemin 85:1299–1308

    Google Scholar 

  7. Venkataramanan R, Starzl TE, Yang S, Burckart GJ, Platchcinski RJ, Shaw BW, Iwatsuki S, van Thiel DH, Sanhui A, Seltman H (1985) Biliary excretion of cyclosporine in liver transplanted patients. Transplant Proc 17:286–289

    PubMed  Google Scholar 

  8. Wagner O, Scheier E, Heitz F, Maurer G (1987) Tissue distribution, disposition, and metabolism of cyclosporine in rats. Drug Metab Dispos 15:377–383

    PubMed  CAS  Google Scholar 

  9. Yee GC, McGuire TR (1990) Pharmacokinetic drug interactions with cyclosporin (Part I). Clin Pharmacokinet 19:319–332

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Tötterman, A., Lalla, M., Salmela, K., Höckerstedt, K. (1992). Cholestasis and kidney dysfunction in liver transplant patients reduces cyclosporine metabolite excretion. In: Kootstra, G., Opelz, G., Buurman, W.A., van Hooff, J.P., MacMaster, P., Wallwork, J. (eds) Transplant International Official Journal of the European Society for Organ Transplantation. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77423-2_59

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-77423-2_59

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-55342-7

  • Online ISBN: 978-3-642-77423-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics